Monday, September 14, 2026

AI Competition Heats Up: South Korea’s Regulatory Hurdles vs. U.S. and China’s Dominance

The U.S. and China enhance AI capabilities with government support, while South Korea faces uncertainty due to AI regulations.

How Ulchi Freedom Shield 2026 is Enhancing U.S.-South Korea Defense Readiness Against North Korea

South Korea and the U.S. will conduct the Ulchi Freedom Shield exercise from August 17 to the 27, involving 18,000 South Korean troops.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

Tag: cancer drug

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Penetrium Bio to unveil U.S. Phase 2 strategy at global symposium

Penetrium Bio will unveil its Phase 2 clinical development strategy for the next-gen cancer drug Penetrium at a global symposium next month.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.